Effect of Daridorexant on the Pharmacokinetics of P-Glycoprotein Substrate Dabigatran Etexilate and Breast Cancer Resistance Protein Substrate Rosuvastatin in Healthy Subjects.
Marion Anliker-OrtJasper DingemanseLuboš JanůPriska KaufmannPublished in: Clinical drug investigation (2023)
NCT05480475; date of registration: 29 July, 2022.